Soleil Boughton - Mar 17, 2023 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: Chief Legal Officer
Signature: /s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Stock symbol: HIMS
Transactions as of: Mar 17, 2023
Transactions value $: -$134,564
Form type: 4
Date filed: 3/20/2023, 05:01 PM
Previous filing: Mar 17, 2023
Next filing: Jun 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HIMS	Class A Common Stock	Sale	-$135K	-13.7K	-7.56%	$9.79	168K	Mar 17, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2022 by the Reporting Person.